Steen Abildstrøm
NovoNordisk (International Medical Director, OSCD & Outcomes)
Bill Abraham
Ohio State University (Professor of Medicine, Division of Cardiovascular Medicine)
Phil Adamson
Abbott (Divisional VP and Medical Officer)
Rosalyn Adigun
FDA, CDER/DCN (Medical Reviewer)
Tariq Ahmad
Yale University, Director (Cardiac Transplant and MCS)
Amrut Ambardekar
University of Colorado (Medical Director of Transplant Program, Director of Clinical Research)
Courtney Ballenger
Project Leader, HFC
Wayne Batchelor
Inova Heart and Vascular Institute (Chief, Interventional Cardiology
Ankeet Bhatt
Kaiser Permanente (Cardiologist, Assistant Professor of Medicine)
Sanjeev Bhavnani
Digital Health Center of Excellence (DHCoE), CDRH, FDA
Ofc of Strategic Partnerships and Tech Innovation (OST)
Robert Blaustein
Merck (Associate Vice-President, Section Head Heart Failure)
Vanessa Blumer
Cleveland Clinic (Advanced HF Fellow)
Roberta Bogaev
Abiomed, Inc (Medical Director, HF)
Biykem Bozkurt
Baylor (Vice-chair of Medicine, Director–Winters Center for HF Research, Associate Director–Cardiovascular Research Institute, Professor of Medicine), Past President, HFSA
Michael Bristow
University of Colorado (Professor of Medicine), ARCA Biopharma (President and CEO)
Javed Butler
Baylor Health System (SVP, Baylor Scott and White health system, President, BSW Research Institute)
Jim Carr
Stealth Biotherapeutics
Cynthia Chauhan
Patient Representative
Johanna Contreras
Icahn School of Medicine at Mount Sinai (Assoc. Professor, Director, Hispanic Heart Center)
Lawton Cooper
Retired NIH, NHLBI (Former Medical Officer)
Maria Costanzo
Midwest CV Institute (HF and Transplant Cardiologist)
Martin Cowie
AstraZeneca (VP Cardiovascular)
Heather Crown
Project Leader, HFC
Piper Dankworth
Patient Representative
Ersilia DeFilippis
Columbia University Irving Medical Center (Advanced HF Cardiologist)
Lorenzo DiCarlo
LivaNova (CMO)
Matt Dimond
Inova Heart and Vascular Institute, Intern
Melvin Echols
Morehouse SOM (Assistant Professor of Medicine)
Michael Felker
Duke University (Director, Cardiovascular Research, Vice-Chief of Cardiology for Clinical Research, Professor of Medicine), BOD, HFSA
Mona Fiuzat
Duke University (Associate Professor of Medicine)
Jonathan Fox
Eidos Therapeutics (President and CMO)
Michael Fritz
Ancora Heart (Vice President, Regulatory Affairs and Quality Assurance)
Marat Fudim
Duke University (Assistant Professor)
Anders Gabrielsen
AstraZeneca (Executive Group Director)
Liz Galle
CRVx (VP of Global Clinical Research)
Richard George
Regeneron (Executive Medical Director,
Clinical Sciences, Global Development; Adjunct Associate Professor of Medicine, Johns Hopkins)
Robin Germany
Zoll Respicardia (Chief Medical Officer)
Al Gianchetti
Xylocor Therapeutics (President and CEO)
John Godwin
Patient Representative
Steven Goedeke
Cardionomic (President/CEO)
Carine Hamo
NYU Langone Health (Assistant Professor of Medicine, Cardiology)
Nasrien Ibrahim
Harvard University (Fellow, Minority Health Policy)
Richard Jacob
Patient Representative
James Januzzi
Massachusetts General Hospital (Hutter Professor of Medicine, Cardiology)
Mohammed Jessa
AstraZeneca (Senior Director–Regulatory affairs)
Mariell Jessup
University of Pennsylvania (Emeritus Professor), American Heart Association (Chief Science and Medical Officer), Past President, AHA
David Kao
University of Colorado, Divisions of Cardiology and Bioinformatics/Personalized Medicine
Robert Kazmierski
FDA, CDRH (Biomedical Engineer)
Shahzeb Khan
Duke University (CV Fellow)
Dalane Kitzman
Wake Forest School of Medicine (Professor, Cardiovascular Medicine and Geriatrics)
Marv Konstam
Tufts Medical Center (Chief Physician Executive), Past President, HFSA
Bettina Kraus
Boehringer-Ingelheim (Senior Global Medical Advisor)
Harlan Krumholz
Yale University (Director of Center for Outcomes Research and Evaluation)
Elizabeth Kunkoski
FDA, Biomedical Engineer
Anu Lala
Icahn School of Medicine at Mount Sinai (Assistant Professor of Medicine)
John Laschinger
Edwards (VP of Medical Affairs for Advanced Technology)
Marty Lefkowitz
Novartis Pharmaceuticals (Therapeutic Area Head, Cardiovascular and Renal)
Eric Leifer
NIH, NHLBI (Mathematical Statistician)
JoAnn Lindenfeld
Vanderbilt University (Director, HF and Transplant Program), Past President, HFSA
Maulik Majmudar
Biofourmis (Co-Founder and Chief Medical Officer)
Fady Malik
Cytokinetics (Executive VP, R&D)
Tre Martyn
Cleveland Clinic (Director of Heart Failure Population Health)
Martin Mendoza
HHS (Director for the Division of Policy and Data, Office of Minority Health)
Phil Mendys
Pfizer (Director, Early Pipeline; Global Medical Affairs)
Robert Mentz
Duke University (Chief, Heart Failure Section)
Masahiro Murakami
Eli Lilly and Company (Senior Medical Advisor)
Joseph Murar
Impulse Dynamics (Medical Director)
Michael Myers
Bristol Myers Squibb (Medical Director, Worldwide Medical CV Products)
Linda Nelson
WhiteSwell (VP of Clinical Affairs)
Wei Ni
Eli Lilly and Company (Research Advisor)
Patrice Nickens
NIH NHLBI (Medical Officer)
Richard Nkulikiyinka
Bayer AG (VP and Head of Therapeutic Area Cardiology & Nephrology, Clinical Department)
Christopher O’Connor
Inova Heart and Vascular Institute (President), Duke University (Professor of Medicine)
Ileana Pina
FDA, CDRH (Medical Reviewer)
Jordan Pomeroy
FDA (Medical Officer, CDER, DCN)
Mitch Psotka
Inova Heart and Vascular Institute, Section Chief (Heart Failure and Transplant), Director (Infiltrative Cardiomyopathy Center)
Lothar Roessig
Bayer (Clinical Development Group Head and VP)
Leonard Sacks
FDA, CDER
Ben Saville
Director & Senior Statistical Scientist (Berry Consultants)
Dan Schaber
Medtronic (VP of HF Clinical Research)
Fred Senatore
FDA (Medical Officer, CDER)
Abhinav Sharma
McGill University (Assistant Professor of Medicine)
Meir Shinnar
FDA (Medical Officer, Circulatory Support Device Branch, Division of Cardiac Devices, Office of Device Evaluation, Center for Devices and Radiological Health)
Scott Solomon
Harvard Medical School (Professor of Medicine ), Brigham and Women’s (Director–noninvasive cardiology)
Randall Starling
Cleveland Clinic (Professor of Medicine), FDA (Member of Circulatory System Devices Panel), Past President, HFSA
Ken Stein
Boston Scientific (Senior VP and CMO for Rhythm Management and Global Health Policy)
Norman Stockbridge
FDA, CDER (Director, Division of Cardiovascular an Renal Products)
Howard Surks
Cardurion (Chief Science Officer, Head of Translational Medicine)
John Teerlink
University of California, San Francisco (Professor of Medicine), San Francisco Veterans Affairs Medical Center (Director of HF Program), President- Elect, HFSA
John Teerlink
San Francisco Veterans Affairs Medical Center (Director of HF Program and Clinical Echocardiography Laboratory), President-Elect, HFSA
Whit Tingley
Tenaya Therapeutics (CMO)
LeTanya Tomlinson
Tenaya Therapeutics (Executive Director, Clinical Operations)
Ellis Unger
Cardiologist (Former Director, Office of Drug Evaluation-1, FDA, CDER)
Muthiah Vaduganathan
Brigham and Women’s, Center for Advanced Heart Disease (Instructor of Medicine)
Orly Vardeny
University of Minnesota (Associate Professor of Medicine)
Vanja Vlajnic
Bayer AG (Sr. Manager, Statistics and Data Insights)
Minnow Walsh
St. Vincent Heart Center (Medical Director), Past President, ACC
David Whellan
Thomas Jefferson University (Associate Provost and Dean for Research), Executive Director, Jefferson Clinical Research Institute
Laura Williams
Patient Representative
Clyde Yancy
Northwestern SOM (Chief of Cardiology, Dept. of Medicine, Vice Dean of Inclusion and Diversity)
Amin Yeyha
Sentara Advanced Heart Failure Center (Advanced HF and Transplant Cardiologist)
Emily Zeitler
Dartmouth (Assistant Professor of Medicine)
Debbie Zeldow
HFSA (Director of Science and Research)
Bram Zuckerman
FDA, CDRH (Director, Division of Cardiovascular Diseases)